|
|
Eleuthero* | |
|
Asian ginseng* | |
| Depletion or interference |
None known |
| Reduced drug absorption/bioavailability |
None known |
| Adverse interaction |
None known |
An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.
Asian ginseng
(Panax ginseng)
In a randomised, double-blind study, 227 people received influenza vaccine plus 100 mg of
standardized extract of Asian ginseng or placebo two times per day for four weeks before and
eight weeks after influenza vaccination.1 Compared with placebo, Asian ginseng
extract was reported to prevent colds and flu,
improve immune cell activity, and increase antibody levels after vaccination.
Eleuthero
Some Russian studies suggest that eleuthero (Siberian ginseng) may reduce the risk of
postvaccination reactions.2
1. Scaglione F, Cattaneo G, Alessandria M, Cogo R. Efficacy and safety of the standardized ginseng extract G 115 for potentiating vaccination against common cold and/or influenza syndrome. Drugs Exptl Clin Res 1996;22:65–72.
2. Zykov MP, Protasova SF. Prospects of immunostimulating vaccination against influenza including the use of Eleutherococcus and other preparations of plants. In New Data on Eleutherococcus: Proceedings of the Second International Symposium on Eleutherococcus, Moscow, 1984, 164–9.
| |||||||